Practical serological assay for the clinical diagnosis of leishmaniasis
AssigneeThe United States of America as represented by the Secretary of the Army
InventorSamuel K. Martin
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe United States of America as represented by the Secretary of the Army
InventorSamuel K. Martin
Estimating the term…
Methods for the diagnosis of visceral, cutaneous and canine leishmaniasis in a subject suspected of being infected with the parasitic protozoa Leishmania is disclosed. Disclosed are antibody-capture enzyme-linked immunosorbent assays (ELISAs) for the detection of antibodies to Leishmania parasite soluble antigens and antigen-capture ELISAs for the detection of Leishmania parasite soluble antigens in host samples. Also disclosed are immunodiagnostic kits for the detection of Leishmania parasite circulating antigens or IgM and IgG antibodies in a sample from subject having visceral, cutaneous or canine leishmaniasis. In these methods and kits, detection may be done photometrically or visually. The methods and kits also allow the visualization of Leishmania amastigotes or promastigotes in a sample.
A protein-free medium comprising an agent that balances the oncotic pressure across a semi-permeable cell membrane and at least one of the following ingredients:
A protein-free medium comprising RPMI Medium 1640, 0.076 mM D, xylose, 25 mM Hepes buffer, L-glutamine, and 30 mM sodium bicarbonate without phenol red.
Dependencies are inferred from the claim text.